Forgot Password

Sign In


  • Company Information

  • Billing Address

  • Are you primarily interested in advertising *

  • Do you want to recieve the HealthTimes Newsletter?

New intelligence on viral gastro poised to curb epidemics

Photo: New intelligence on viral gastro poised to curb epidemics
Outbreaks of gastro sweeping schools, aged-care homes and hospital wards could become far less frequent, with targeted research on a key virus only recently possible - and an early study set to define new parameters around the longevity and infectivity of this highly contagious stomach bug.

Norovirus is common around the world and responsible for the majority of gastroenteritis outbreaks, with around 700 million people contracting the short but severe illness each year including 1.8 million Australians, and no vaccine or cure yet available.

In the developed world most patients recover in days, however vulnerable people - including the elderly and those with compromised immune systems - are at risk of more serious outcomes and longer recovery times.

Although patients return to school or work a day or two after symptoms cease, they may continue to shed the virus for weeks or even months. Until recently, it has been impossible to study the live virus to comprehensively understand the potential of these shedded particles to infect others.
“It’s only in the past two years that technology has enabled us to develop live norovirus cultures in the lab,” Associate Professor Jill Carr of Flinders University explains. “Before then, researchers have only been able to make assumptions on this unique virus based on those with similar attributes.”

Associate Professor Carr is leading world-first research to find out how shedded norovirus materials behave, including their ability to cause infection and the impact of disinfectants on the notoriously resilient virus.

She is adapting methodology developed at the South Australian Health and Medical Research Institute (SAHMRI) to grow cells from the gut and infect these with norovirus. The study will further employ new technology at the Flinders Cell Screen SA facility to screen large quantities of samples.

“We know people will continue to shed the virus for some time after their illness, but we do not know how infectious these particles are,” she says.

The economic burden of norovirus is huge and was estimated at more than US$44 billion globally in 2017 including healthcare impact, lost productivity and other societal costs.

A better understanding is likely to lead to fewer and shorter-lived outbreaks.

The Flinders University study is funded by a 2018 Flinders Foundation Seed Grant and is being carried out in collaboration with SAHMRI.


Thanks, you've subscribed!

Share this free subscription offer with your friends

Email to a Friend

  • Remaining Characters: 500